GoodRx Settles Data Sharing Class Action Lawsuit for $25 Million

Case Overview: GoodRx has reached a $25 million settlement in a class action lawsuit alleging unauthorized sharing of user health data with third parties.

Consumers Affected: Individuals in the United States who used GoodRx's websites, apps, or services.

Court: U.S. District Court for the Northern District of California

GoodRx, a telehealth and prescription discount service, has agreed to a $25 million settlement in a lawsuit alleging unauthorized sharing of users' personal health information with third parties like Facebook, Google, and Criteo. 

The proposed settlement, pending preliminary court approval, aims to compensate users whose data was allegedly shared without their consent between 2017 and 2020.

GoodRx Accused of Sharing User Health Data Without Consent

The consolidated lawsuit, filed in the U.S. District Court for the Northern District of California, alleged that GoodRx utilized website tracking technologies to share user data for advertising purposes. Plaintiffs claimed these practices violated multiple state and federal privacy laws, including the California Confidentiality of Medical Information Act and the California Consumer Legal Remedies Act.

The lawsuit followed an earlier Federal Trade Commission (FTC) enforcement against GoodRx. In February 2023, the FTC alleged that GoodRx’s data sharing violated the Health Breach Notification Rule and the FTC Act. As part of that enforcement, GoodRx agreed to pay $1.5 million in civil penalties and implement measures to protect consumer information.

Following the FTC's action, multiple class action lawsuits were filed against GoodRx, which were later consolidated. The consolidated lawsuit not only targeted GoodRx but also named Facebook, Google, and Criteo as co-defendants. These companies are accused of receiving and utilizing the shared data for targeted advertising without user consent.

$25 Million Settlement Reached in GoodRx Data Sharing Lawsuit

If the settlement receives court approval, it will cover all individuals in the United States who used GoodRx's websites, apps, or services before the preliminary approval date. Eligible users will need to submit a valid claim form, either by mail or through the settlement's official website once it becomes available. The amount each claimant will receive depends on the number of approved claims.

"At this time, it is not known precisely how much each Authorized Claimant will receive from the Settlement Payment or when payments will be made," court documents state. "The amount of the Settlement Payment will depend on the number of claims that receive approval."

Legal Action Continues Against Facebook, Google, and Criteo

While GoodRx has agreed to the $25 million settlement, the legal proceedings continue against the other named companies. The co-defendants are reportedly seeking dismissal of the claims against them. If the court approves GoodRx's settlement, plaintiffs will still have the opportunity to pursue their cases against Facebook, Google, and Criteo.

"Settlement Class Members will receive immediate monetary relief from the Settlement Fund while still retaining the potential for additional recoveries from the remaining Co-Defendants," the plaintiffs' motion for preliminary approval states. "The Settlement Class will also benefit from documents and information GoodRx has agreed to provide as part of the Settlement, that Plaintiffs can use in their pursuit of their claims against the Co-Defendants."

GoodRx has maintained that it addressed the issues related to data sharing nearly three years before the FTC's investigation. The company stated that it believed its practices were compliant with regulations but chose to settle to avoid prolonged legal disputes.

InjuryClaims.com will provide updates on the GoodRx data sharing class action settlement website's availability.

Case Details

• Lawsuit: Doe et al. v. GoodRx Holdings, Inc. et al.
• Case Number: 3:23-cv-00501
• Court: U.S. District Court for the Northern District of California

Plaintiffs' Attorneys

• Christian Levis, Amanda Fiorilla, and Rachel Kesten (Lowey Dannenberg, P.C.)
• L. Timothy Fisher and Jenna L. Gavenman (Bursor & Fisher, P.A.)
• Willem F. Jonckheer, Robert C. Schubert, and Amber L. Schubert (Schubert Jonckheer & Kolbe LLP)
• Mark L. Javitch (Javitch Law Office)
• Thomas A. Zimmerman, Jr. (Zimmerman Law Offices, P.C.)
• Israel David (Israel David LLC)
• Rebecca M. Hoberg (Moya Law Firm)
• Jonathan Shub, Benjamin F. Johns, and Samantha E. Holbrook (Shub & Johns LLC)

Have you used GoodRx? What are your thoughts on this settlement? Share your opinion in the comments below.